Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Global Drug Delivery in Cancer Market Study 2015-2024 - Profiles of 231 Companies Along with Their 266 Collaborations | ||
By: PR Newswire Association LLC. - 07 Oct 2015 | Back to overview list |
|
DUBLIN, Oct. 07 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/zgw67s/drug_delivery_in) has announced the addition of Jain PharmaBiotech's new report "Drug Delivery in Cancer - Technologies, Markets and Companies" to their offering. The market value of drug delivery technologies and the anticancer drugs are difficult to separate. Cancer market estimates from 2014-2024 are given according to organs involved and the types of cancer as well as according to technologies. Distribution of the into major regions is also described. Innovative cancer therapies are based on current concepts of molecular biology of cancer. These include antiangiogenic agents, immunotherapy, bacterial agents, viral oncolysis, targeting of cyclic-dependent kinases and tyrosine kinase receptors, antisense approaches, gene therapy and combination of various methods. Important methods of immunotherapy in cancer involve use of cytokines, monoclonal antibodies, cancer vaccines and immunogene therapy. 4. Delivery of Biological Therapies for Cancer Part II: Companies 8. Companies involved in cancer drug delivery For more information visit http://www.researchandmarkets.com/research/zgw67s/drug_delivery_in Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net SOURCE Research and Markets |
||
|
||
Copyright 2015 PR Newswire Association LLC. | Back to overview list |